Evidence map›Paper›PMID 36817915›Full record

ArticleFrontiers in public health2023

PM

Wenjing Zhang, Zinan Li, Guojun Li, Ling Kong, Haiming Jing, Nan Zhang, Junyu Ning, Shan Gao, Yong Zhang, Xinyu Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wenjing ZhangBeijing Center for Disease Prevention and Control, Beijing, China.
Zinan LiBeijing Center for Disease Prevention and Control, Beijing, China.
Guojun LiBeijing Center for Disease Prevention and Control, Beijing, China.
Ling KongBeijing Center for Disease Prevention and Control, Beijing, China.
Haiming JingBeijing Center for Disease Prevention and Control, Beijing, China.
Nan ZhangBeijing Center for Disease Prevention and Control, Beijing, China.
Junyu NingBeijing Center for Disease Prevention and Control, Beijing, China.
Shan GaoBeijing Center for Disease Prevention and Control, Beijing, China.
Yong ZhangBeijing Center for Disease Prevention and Control, Beijing, China.
Xinyu WangBeijing Center for Disease Prevention and Control, Beijing, China.
Jing TaoBeijing Center for Disease Prevention and Control, Beijing, China.
Beijing Center for Disease Prevention and Control · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Exposure to fine particulate matter (PM), especially PM Methods: Water-soluble components of PM Results: Body length and lifespan were shortened by exposure to WS-PM Conclusion: WS-PM

Indexed as

Caenorhabditis elegansLipid Metabolism DisordersAnimalsInsulinInsulin-Like Growth Factor ILipid MetabolismLongevityParticulate MatterRNASignal TransductionInsulinInsulin-Like Growth Factor IParticulate MatterRNACaenorhabditis elegansgene homologyhealthspanlifespanPM2.5RNA-Sequencing

Identifiers

PMID36817915
PMCPMC9932997
OpenAlexW4318984989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.